Generating and communicating evidence in COVID-19 treatment and vaccine development
Download a PDF of the presentation.
As we return to standard reimbursement processes and evidence requirements, we will continue to face challenges from a continually changing environment.
In this one-hour webinar, we’ll look at the opportunities and challenges that exist when creating HEOR materials in a dynamic setting and outline a set of best practices for developing evidence-based communication materials for emergent infectious diseases.
What you will learn:
- Overview of vaccine and drug development
- Key challenges for developing robust literature reviews, dossiers, and economic models
- Best practices in emergent diseases
Shahnaz Khan, MPH
Executive Director, Market Access and Outcomes Strategy
Anne Heyes, MBA
Vice President, Head Market Access and Outcomes Strategy, Europe
Kati Copley-Merriman, MBA
Vice President, Market Access and Outcomes Strategy
Michele Wilson, MSPH
Senior Director, Health Economics